Side effects from fluticasone may depend on the form, dose, and the individual. They may range from runny nose, sneezing, and watery eyes to skin scaling, wheezing, and shortness of breath. Share on ...

Asthma warning: Adults with asthma who take drugs such as salmeterol alone have an increased risk of death from asthma problems. Also, children and adolescents with asthma who take salmeterol alone ...

Fluticasone is a type of corticosteroid drug that helps reduce inflammation. It is available as a nasal spray, inhaled corticosteroid, or topical cream or ointment. Doctors recommend ...

The safe and appropriate use of long-acting beta-agonists (LABAs) for the treatment of asthma has been widely debated. In two large clinical trials, investigators found a potential risk of serious ...

Objective: To test the hypothesis that once-daily treatment with fluticasone propionate is as effective as twice-daily treatment in children with well controlled asthma. Design: Multicentre, ...

Discover comprehensive details about Fluticasone, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated prescription ...

Credit: Shutterstock. According to the results of a recently published systematic review, the combination of intranasal azelastine plus fluticasone is more effective in reducing symptom scores in ...

Objective: To compare the efficacy and tolerability of a salmeterol/fluticasone propionate (FP) combination product (50/100µg twice daily) with budesonide (BUD) at a four-fold higher microgram dose ...

An exhalation system with fluticasone was shown to significantly reduce nasal polyp score at 4 and 16 weeks compared with placebo, with improvements also observed in several patient-reported outcomes.

Dysphagia Not Tied to Post-Anterior Cervical Op Swelling Swallowing aerosolized fluticasone improves histologic eosinophilia but does not improve dysphagia symptoms in adults with eosinophilic ...

Most guidelines recommend either a long-acting beta-agonist (LABA) plus an inhaled glucocorticoid or a long-acting muscarinic antagonist (LAMA) as the first-choice treatment for patients with chronic ...